Luka A. Clarke

2.0k total citations
51 papers, 1.5k citations indexed

About

Luka A. Clarke is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Luka A. Clarke has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in Luka A. Clarke's work include Cystic Fibrosis Research Advances (18 papers), Neonatal Respiratory Health Research (11 papers) and Advanced biosensing and bioanalysis techniques (11 papers). Luka A. Clarke is often cited by papers focused on Cystic Fibrosis Research Advances (18 papers), Neonatal Respiratory Health Research (11 papers) and Advanced biosensing and bioanalysis techniques (11 papers). Luka A. Clarke collaborates with scholars based in Portugal, United Kingdom and Germany. Luka A. Clarke's co-authors include Margarida D. Amaral, Francisco M. Couto, Hugo Alexandre Ferreira, P. P. Freitas, André Lamúrias, Daniel L. Graham, Robert I. McLachlan, Dirk Schindelhauer, D. C. Irby and David Robertson and has published in prestigious journals such as Cell, The Journal of Cell Biology and Applied Physics Letters.

In The Last Decade

Luka A. Clarke

51 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luka A. Clarke Portugal 21 752 401 172 130 122 51 1.5k
Thomas N. Krogh Denmark 17 735 1.0× 107 0.3× 191 1.1× 57 0.4× 53 0.4× 24 1.4k
Howard Davies United Kingdom 24 724 1.0× 101 0.3× 83 0.5× 119 0.9× 87 0.7× 68 1.4k
Henk P.J. Buermans Netherlands 21 1.8k 2.4× 183 0.5× 310 1.8× 124 1.0× 76 0.6× 32 2.5k
Kenji Murakami Japan 24 1.2k 1.6× 588 1.5× 182 1.1× 186 1.4× 48 0.4× 112 2.5k
Kimmo Palin Finland 19 2.2k 2.9× 175 0.4× 412 2.4× 231 1.8× 29 0.2× 36 3.1k
Steve Lefever Belgium 24 1.6k 2.1× 318 0.8× 343 2.0× 72 0.6× 96 0.8× 47 2.2k
Pamela S. Adams United States 18 801 1.1× 289 0.7× 225 1.3× 55 0.4× 24 0.2× 28 1.9k
Martin Baumgartner Switzerland 26 1.2k 1.6× 195 0.5× 82 0.5× 247 1.9× 56 0.5× 78 2.1k
Tineke Veenendaal Netherlands 22 597 0.8× 293 0.7× 245 1.4× 92 0.7× 15 0.1× 42 1.4k

Countries citing papers authored by Luka A. Clarke

Since Specialization
Citations

This map shows the geographic impact of Luka A. Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luka A. Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luka A. Clarke more than expected).

Fields of papers citing papers by Luka A. Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luka A. Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luka A. Clarke. The network helps show where Luka A. Clarke may publish in the future.

Co-authorship network of co-authors of Luka A. Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Luka A. Clarke. A scholar is included among the top collaborators of Luka A. Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luka A. Clarke. Luka A. Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Botelho, Hugo M., Miquéias Lopes‐Pacheco, Madalena C. Pinto, et al.. (2025). Global functional genomics reveals GRK5 as a cystic fibrosis therapeutic target synergistic with current modulators. iScience. 28(3). 111942–111942. 2 indexed citations
2.
Clarke, Luka A. & Margarida D. Amaral. (2023). What Can RNA-Based Therapy Do for Monogenic Diseases?. Pharmaceutics. 15(1). 260–260. 8 indexed citations
3.
Fejes, Zsolt, Ferenc Fenyvesi, Judit Váradi, et al.. (2021). Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells. Frontiers in Pharmacology. 12. 592184–592184. 11 indexed citations
4.
Silva, Iris A. L., Luka A. Clarke, Hugo M. Botelho, et al.. (2020). Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: The case of S955P and 1717-2A>G. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(11). 165905–165905. 12 indexed citations
5.
Clarke, Luka A., et al.. (2019). TMEM16A chloride channel does not drive mucus production. Life Science Alliance. 2(6). e201900462–e201900462. 29 indexed citations
6.
Lamúrias, André, et al.. (2017). Generating a Tolerogenic Cell Therapy Knowledge Graph from Literature. Frontiers in Immunology. 8. 1656–1656. 7 indexed citations
7.
8.
Clarke, Luka A., Lisete Sousa, Celeste Barreto, & Margarida D. Amaral. (2013). Changes in transcriptome of native nasal epithelium expressing F508del-CFTR and intersecting data from comparable studies. Respiratory Research. 14(1). 38–38. 56 indexed citations
9.
Almaça, Joana, Diana Faria, Marisa Sousa, et al.. (2013). High-Content siRNA Screen Reveals Global ENaC Regulators and Potential Cystic Fibrosis Therapy Targets. Cell. 154(6). 1390–1400. 43 indexed citations
10.
Martins, Joana Raquel, Patthara Kongsuphol, Eva Sammels, et al.. (2011). F508del-CFTR increases intracellular Ca2+ signaling that causes enhanced calcium-dependent Cl− conductance in cystic fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(11). 1385–1392. 33 indexed citations
11.
Ramalho, Anabela S., Luka A. Clarke, & Margarida D. Amaral. (2011). Quantification of CFTR Transcripts. Methods in molecular biology. 741. 115–135. 5 indexed citations
12.
Ramachandran, Shyam, Luka A. Clarke, Todd E. Scheetz, Margarida D. Amaral, & Paul B. McCray. (2011). Microarray mRNA Expression Profiling to Study Cystic Fibrosis. Methods in molecular biology. 742. 193–212. 9 indexed citations
13.
Ferreira, Hugo Alexandre, et al.. (2005). Rapid DNA hybridization based on ac field focusing of magnetically labeled target DNA. Applied Physics Letters. 87(1). 26 indexed citations
14.
Clarke, Luka A., et al.. (2005). The replication timing of CFTR and adjacent genes. Chromosome Research. 13(2). 183–194. 9 indexed citations
15.
Ferreira, Hugo Alexandre, et al.. (2005). Detection of cystic fibrosis related DNA targets using AC field focusing of magnetic labels and spin-valve sensors. IEEE Transactions on Magnetics. 41(10). 4140–4142. 30 indexed citations
16.
Galvin, Paul, et al.. (2004). Microarray analysis in cystic fibrosis. Journal of Cystic Fibrosis. 3. 29–33. 19 indexed citations
17.
Clarke, Luka A., et al.. (2000). Pathological exon skipping in an HNPCC proband with MLH1 splice acceptor site mutation. Genes Chromosomes and Cancer. 29(4). 367–370. 2 indexed citations
18.
Clarke, Luka A., Peter Jordan, & Maria Guida Boavida. (2000). Cell type specificity in alternative splicing of the human mismatch repair gene hMSH2. European Journal of Human Genetics. 8(5). 347–352. 6 indexed citations
19.
Jabbour, HN, et al.. (1998). Alternative splicing of the prolactin receptor gene generates a 1.7 kb RNA transcript that is linked to prolactin function in the red deer testis. Journal of Molecular Endocrinology. 21(1). 51–59. 10 indexed citations
20.
Jabbour, HN, Luka A. Clarke, Sheila C. Boddy, et al.. (1996). Cloning, sequencing and functional analysis of a truncated cDNA encoding red deer prolactin receptor: an alternative tyrosine residue mediates β-casein promoter activation. Molecular and Cellular Endocrinology. 123(1). 17–26. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas N. Krogh Breakdown of academic impact, for papers by Howard Davies Breakdown of academic impact, for papers by Henk P.J. Buermans Breakdown of academic impact, for papers by Kenji Murakami Breakdown of academic impact, for papers by Kimmo Palin Breakdown of academic impact, for papers by Steve Lefever Breakdown of academic impact, for papers by Pamela S. Adams Breakdown of academic impact, for papers by Martin Baumgartner Breakdown of academic impact, for papers by Tineke Veenendaal
Rankless by CCL
2026